G
Garth J. S. Cooper
Researcher at University of Auckland
Publications - 309
Citations - 17579
Garth J. S. Cooper is an academic researcher from University of Auckland. The author has contributed to research in topics: Amylin & Insulin. The author has an hindex of 63, co-authored 299 publications receiving 16490 citations. Previous affiliations of Garth J. S. Cooper include Manchester Academic Health Science Centre & University of Manchester.
Papers
More filters
Journal ArticleDOI
Identification of elevated urea as a severe, ubiquitous metabolic defect in the brain of patients with Huntington's disease
Stefano Patassini,Paul Begley,Suzanne J. Reid,Jingshu Xu,Stephanie J. Church,Maurice A. Curtis,Mike Dragunow,Henry J. Waldvogel,Richard D. Unwin,Russell G. Snell,Richard L.M. Faull,Garth J. S. Cooper +11 more
TL;DR: Brain urea metabolism is a target for generating novel monitoring/imaging strategies and/or therapeutic interventions aimed at ameliorating the impact of HD in patients, and hypothesize that defective brain Urea metabolism could play a substantive role in the pathogenesis of neurodegeneration, perhaps via defects in osmoregulation or nitrogen metabolism.
Journal ArticleDOI
Metabolomic analysis of rat serum in streptozotocin-induced diabetes and after treatment with oral triethylenetetramine (TETA).
Marta Ugarte,Marie Brown,Katherine A. Hollywood,Garth J. S. Cooper,Paul N. Bishop,Warwick B. Dunn +5 more
TL;DR: Metabolomic studies have shown that the STZ-induced rat model of diabetes is an appropriate model system to undertake research into diabetes and potential therapies as several metabolic changes observed in humans and other animal models were also observed in this study.
Journal ArticleDOI
Proteomic characterization of human serum proteins associated with the fat‐derived hormone adiponectin
TL;DR: It is demonstrated that, in the circulation, adiponectin forms protein complexes with other serum proteins that might serve as the physiological‐binding partners of adiponECTin and regulate its bioavailability and biological activities.
Journal ArticleDOI
Tetracycline Treatment Retards the Onset and Slows the Progression of Diabetes in Human Amylin/Islet Amyloid Polypeptide Transgenic Mice
Jacqueline F. Aitken,Kerry M. Loomes,David Scott,S. Reddy,Anthony R. J. Phillips,Gordana Prijic,Chathurini Fernando,Shaoping Zhang,Ric Broadhurst,Phil L'Huillier,Garth J. S. Cooper +10 more
TL;DR: This is the first report to show that treating hA/hIAPP transgenic mice with a modifier of hA-IAPP misfolding can ameliorate their diabetic phenotype, and may have potential for treating or preventing type 2 diabetes.
Journal ArticleDOI
Amylin secretion from the perfused pancreas: Dissociation from insulin and abnormal elevation in insulin-resistant diabetic rats
TL;DR: These studies provide the first evidence that there is a mechanism within the pancreas whereby independent secretion of amylin and insulin can occur and the molar ratio ofAmylin to insulin secreted from both normal and diabetic pancreases can vary over a wide range.